Full View

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer

N Nishioka, T Naito, A Notsu, K Mori… - Cancer …, 2021 - Wiley Online Library
Background Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …
被引用次数：22 相关文章
[PDF] archive.org

[PDF][PDF] Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer

N Nishioka, T Naito, A Notsu, K Mori… - Cancer …, 2021 - scholar.archive.org
Background: Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer

N Nishioka, T Naito, A Notsu, K Mori… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …
[HTML] nih.gov

[HTML][HTML] Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer

N Nishioka, T Naito, A Notsu, K Mori, H Kodama… - Cancer …, 2021 - ncbi.nlm.nih.gov
Background Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer.

N Nishioka, T Naito, A Notsu, K Mori, H Kodama… - Cancer …, 2020 - europepmc.org
Background Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer.

N Nishioka, T Naito, A Notsu, K Mori… - Cancer …, 2021 - search.ebscohost.com
Background: Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …

Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer

N Nishioka, T Naito, A Notsu, K Mori… - Cancer …, 2021 - search.proquest.com
Background Quantitative skeletal muscle mass loss has the potential to predict the
therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of …